Skip to main content

Closed

RLYB: Rallybio Corporation Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

89thpctl

Volume

0.07×avg

Market Cap

84.54MUSD

P/E Ratio

-10.7TTM

Div Yield

-ann

Rallybio Corporation

RLYBNASDAQ Capital Market·USD·Closed

Rallybio Corporation

RLYBNASDAQ·USD·Closed

$15.93

−0.87%

$15.93

−$0.14 (0.87%)

52W Range

89thpctl

Volume

0.07×avg

Mkt Cap

84.54MUSD

P/E

-10.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings